Jonathan Davis, MD, MPHS
3.2K posts
@JonathanDavisHF
Director @sfhealthnetwork HF Program Zuckerberg SF General Hospital @zsfgcare @ucsfcardiology. New Dad x2! Alum @WUSTLmed⬅️ @UCSFmedicine⬅️ @cornell he/his/him
Heart failure colleagues. I would propose a new focus of emphasis Re the acute Rx of newly decompensated systolic failure. We should favor afterload reduction FIRST. Seminal Beta-blocker trials were in ambulatory outpts. Giving BB to decompensated failure is a mistake. IMO.
Join Editor in Chief @JasonKatzMD and Deputy Editor @noshreza for JCF-I Office Hours! Answering your questions on: ✅the journal’s inaugural publications ✅what they are looking for in submissions ✅exciting updates on what’s to come 🔗 Registration: bit.ly/3Hu9SRo
Among 1,498 CICU patients with cardiogenic shock, the need for renal replacement therapy (RRT)—especially CRRT—is strongly associated with worse outcomes. 📉 In-hospital mortality for CRRT: 56% 📈 One-year survival: <30% 🧵 Key findings below: 🔗 bit.ly/3Utjz5w
